Edesa Biotech, Inc.EDSANASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank80
3Y CAGR-3.4%
5Y CAGR-9.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-3.4%/yr
vs +30.9%/yr prior
5Y CAGR
-9.0%/yr
Recent acceleration
Acceleration
-34.3pp
Decelerating
Percentile
P80
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.30M | +6.6% |
| 2025 | $7.79M | +11.1% |
| 2024 | $7.01M | -23.9% |
| 2023 | $9.22M | -47.6% |
| 2022 | $17.59M | +31.9% |
| 2021 | $13.34M | +98.8% |
| 2020 | $6.71M | +113.6% |
| 2019 | $3.14M | -35.2% |
| 2018 | $4.84M | -1.5% |
| 2017 | $4.92M | - |